ADM Tronics is engaged in the development, manufacture and sale of chemical products to industrial users.
| Revenue (Most Recent Fiscal Year) | $3.20M |
| Net Income (Most Recent Fiscal Year) | $-0.12M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 2.04 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 7.80 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -3.81% |
| Net Margin (Trailing 12 Months) | -3.87% |
| Return on Equity (Trailing 12 Months) | -15.66% |
| Return on Assets (Trailing 12 Months) | -5.89% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.23 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.86 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 5.32 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.01 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $0.00 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 67.59M |
| Free Float | 18.25M |
| Market Capitalization | $6.86M |
| Average Volume (Last 20 Days) | 0.02M |
| Beta (Past 60 Months) | 0.24 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 73.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |